We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Membrane Bound Enzyme Regulates Killer T-cells

By Biotechdaily staff writers
Posted on 04 Jul 2002
Researchers have isolated and characterized a membrane bound enzyme called signal peptide peptidase (SPP) that plays a key role in regulating the activity of immune killer T cells. More...
SSP was found to be a member of the family of proteolytic enzymes known as aspartic proteases. A paper published in the June 20, 2002, issue of Science reports that SSP modulates intramembrane proteolysis of signal peptides after they have been cleaved from molecules of the major histocompatibility complex I (MHC-I).

T cells "examine” the protein fragments on the cell surface, and if they recognize them, the T cells move on. If, however, the T cells do not recognize the fragments, the cell may be hosting a virus or manufacturing mutant proteins (as in the case of cancer). The T cells then react by attacking and killing the diseased cells. Recognition is due to the presence in the cell membrane of MHC-I fragments that have been generated by SSP proteolysis. If killer T cells detect insufficient levels of MHC-I protein fragments, they attack and destroy the suspect cell.

"Our research is a small part of the larger problem of how viruses and diseased cells ravage the body and circumvent our immune system, says Kathleen Binns, author of the paper and a doctoral student in medical genetics and microbiology at the University of Toronto (Canada). "This research gives us a better understanding of how the immune system works. As a result, we have a better understanding of how viruses and cancer try to get around this process. One day, we will hopefully be able to develop treatments and therapies to counter these rogue cells.”



Related Links:
University of Toronto

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Portable POCT Blood Gas Analyzer
BD100
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.